Compare ERC & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ERC | TOI |
|---|---|---|
| Founded | 2003 | 2007 |
| Country | United States | United States |
| Employees | N/A | 641 |
| Industry | Finance/Investors Services | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 259.5M | 304.4M |
| IPO Year | N/A | N/A |
| Metric | ERC | TOI |
|---|---|---|
| Price | $9.27 | $3.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.67 |
| AVG Volume (30 Days) | 61.4K | ★ 1.9M |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | ★ 8.37% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $30.15 |
| Revenue Next Year | N/A | $25.77 |
| P/E Ratio | $12.88 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.72 | $1.80 |
| 52 Week High | $9.78 | $4.88 |
| Indicator | ERC | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 58.84 | 59.94 |
| Support Level | $9.25 | $3.31 |
| Resistance Level | $9.50 | $3.74 |
| Average True Range (ATR) | 0.13 | 0.23 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 94.83 | 77.50 |
Allspring Multi-Sector Income Fund is a closed-end investment management company. The company's core business is to secure a high level of income for its investors consistent with limiting its overall exposure to domestic interest rate risk. It invests in U.S. dollar-denominated below investment-grade bonds, debentures, and other income obligations, including loans and preferred stocks, developed and emerging market debt securities, including obligations of foreign governments or governmental entities, foreign corporations, or supranational agencies denominated in various currencies, asset backed securities and investment grade corporate bonds.
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.